CRISPR Therapeutics AG SEC filings CRSP
CRISPR Therapeutics AG has 880 filings in SEC EDGAR's recent list, going back to May 13, 2016. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Jul 13, 2022 | — |
| CORRESP | Letter to the SEC | Jun 23, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 13, 2022 | — |
| D/A | Filing | Apr 10, 2020 | — |
| D | Filing | Apr 9, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 30, 2019 | — |
| CORRESP | Letter to the SEC | Apr 29, 2019 | — |
| PRER14A | Filing | Apr 29, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 26, 2019 | — |
| CORRESP | Letter to the SEC | Apr 23, 2019 | — |
| PRER14A | Filing | Apr 23, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 19, 2019 | — |
| CT ORDER | Filing | Nov 30, 2018 | — |
| CT ORDER | Filing | Dec 21, 2017 | — |
| EFFECT | Filing | Dec 4, 2017 | — |
| CORRESP | Letter to the SEC | Dec 1, 2017 | — |
| CORRESP | Letter to the SEC | Dec 1, 2017 | — |
| UPLOAD | Letter from the SEC | Dec 1, 2017 | — |
| CT ORDER | Filing | Jan 13, 2017 | — |
| D | Filing | Nov 4, 2016 | — |
| EFFECT | Filing | Oct 18, 2016 | — |
| CERTNAS | Auto-generated paper document | Oct 18, 2016 | — |
| CT ORDER | Filing | Oct 18, 2016 | — |
| 8-A12B | Form 8-a12b | Oct 18, 2016 | — |
| CORRESP | Letter to the SEC | Oct 14, 2016 | — |
| CORRESP | Letter to the SEC | Oct 14, 2016 | — |
| UPLOAD | Letter from the SEC | Oct 14, 2016 | — |
| CORRESP | Letter to the SEC | Sep 9, 2016 | — |
| DRSLTR | Filing | Sep 2, 2016 | — |
| UPLOAD | Letter from the SEC | Aug 26, 2016 | — |
| DRS/A | Filing | Aug 19, 2016 | — |
| DRS/A | Filing | Aug 12, 2016 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2016 | — |
| DRS/A | Filing | Jul 27, 2016 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2016 | — |
| DRS/A | Filing | Jul 8, 2016 | — |
| DRS/A | Filing | Jun 29, 2016 | — |
| UPLOAD | Letter from the SEC | Jun 13, 2016 | — |
| DRS | Filing | May 13, 2016 | — |
Showing 39 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CRSP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Switzerland
- Headquarters
- Zug
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1674416
- Former names
- CRISPR Therapeutics AG (until Nov 2, 2026)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.